EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. - Wikidata - awgldk - TriplyDB

EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.

EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.

http://www.wikidata.org/entity/Q46706250

about

ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias Guidance molecules in lung cancer Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors.EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase Proteomics of breast cancer: principles and potential clinical applications.EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.Goosecoid promotes the metastasis of hepatocellular carcinoma by modulating the epithelial-mesenchymal transition.ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia.Implication of microsatellite instability in human gastric cancers.Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.EPH-EPHRIN in human gastrointestinal cancers Dancing with the dead: Eph receptors and their kinase-null partners.Regulation and misregulation of Eph/ephrin expression.Control of blood vessel identity: from embryo to adult.Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion.A review on Eph/ephrin, angiogenesis and lymphangiogenesis in gastric, colorectal and pancreatic cancers Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential.Ephrin b2 receptor and microsatellite status in lymph node-positive colon cancer survival.Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients.In situ validation of an intestinal stem cell signature in colorectal cancer.Sex-determination gene SRY potentially associates with poor prognosis but not sex bias in hepatocellular carcinoma.Complementary expression and repulsive signaling suggest that EphB receptors and ephrin-B ligands control cell positioning in the gastric epithelium.Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.

P2860

Q24338588-64B2F19D-2BBF-49DB-9BC0-B52FBF97C932 Q24598659-F638BD5B-9374-4AF7-8751-DA4A05B6ED42 Q30489704-88CB89DA-495B-4FD2-B3C8-0442FA6CDF5C Q30514025-2C26838D-5E64-4D17-B5B3-FFBA4AD8A93F Q33245053-88DD8701-ED29-49FB-8F46-83445030F654 Q33245402-55C87824-9103-4840-9790-4C2248B5E190 Q33778296-B7185E10-2AA2-4BC0-A13C-487043DC981C Q34400426-F474A347-CACD-453A-AD74-16936B29D310 Q35772903-FBDBE1B6-80DE-46CD-8CC6-23276481C4DB Q35783568-CBBF135D-C7AC-456A-9B25-949A988C3A01 Q35828517-98EEA803-4818-4C2E-A4A6-D4D02C1CD1BB Q36107605-5049DA78-1E89-427C-9138-5C8EE5B3E432 Q36116625-61DA55F1-07C0-491C-B303-D21966461B6F Q37160698-E1D92E27-3EA2-44CB-B419-4A087DCF1E80 Q37627879-72B6795A-75BB-434C-8B71-143C61C79E9F Q37824603-88C56C1B-D4D8-4B33-8B94-BF977DA9F313 Q37860149-FFF15814-6901-44F1-BEE3-D828BD0FD0BB Q38008491-8C5FF502-505E-43E0-9DB1-2E7A9A362C22 Q39370974-A380467C-6681-49F7-B572-2EB0B8C696FF Q40448540-55B9CFA2-BC26-4B9C-8AC6-B536022917CB Q41662329-D4D76ADD-DB81-49C9-AE09-26DA8CB50AEB Q42125248-EC9F8F3C-7631-499B-832A-90A6F657B9EC Q42684763-45C3046A-0F70-4C14-9D37-7AC2F7E7B1B6 Q45907873-92BC8584-8DD9-43AC-8BD2-83C8AD70449E Q46080136-5331B023-0C1F-4478-B012-470078FBFA96 Q53155506-1B3BACD3-A9E2-4CAE-9291-7DE3632B271F Q54345903-96E1835C-2464-4B89-8A36-B98D2ADCC9A7 Q54626344-CB2D4A0C-AAA6-43F8-B2C3-5928E06BB155 Q55286883-4468D83F-4031-489D-80AD-E1D24DA45A51

P2860

EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.

http://www.wikidata.org/entity/Q46706250

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@en

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@nl

type

label

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@en

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@nl

prefLabel

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@en

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@nl

P1433

Q46706250-16BFA58D-95A2-4D11-BD41-DD8A698E3014

P1476

Q46706250-2F84D018-2004-4531-8112-8C9E4F439E35

P2093

Q46706250-2208B94F-C397-463F-A7BA-E4727430933B

Q46706250-36A88E2C-8D10-4602-8E1A-81B9674A2997

Q46706250-4F291224-8328-46F9-ACAD-230AD5E54C2F

Q46706250-53C9D7CB-A42E-4C2E-94B3-E7A8F9998E72

Q46706250-5A3DC00C-2198-49D7-B3BB-BA081D026AC9

Q46706250-6D1ABDCF-1709-4B80-817B-41C2C85DC668

Q46706250-CCBA2300-ADC2-41B8-96A0-95F01E889078

Q46706250-D8859642-3F34-490A-A4FF-FB4D83163D86

Q46706250-E738633C-0416-4099-99F8-F6889C4EBCD7

Q46706250-EA202228-3482-485D-9090-4C8B145C639B

P304

Q46706250-36946A7A-AFEB-47AE-B494-2BB053137E17

P31

Q46706250-BB07B0B0-534E-4B2A-B373-AF49BC710AA0

P356

Q46706250-33CEC1FA-78FC-4FB5-AAD9-F2B9316FA2D6

P407

Q46706250-E2E7B89E-301E-4979-B338-7D01555A3B9B

P433

Q46706250-E5664FF4-83AD-4C9F-B697-3CAC8BD371DF

P478

Q46706250-A4286BC7-335C-401B-83AC-324E88BDF52C

P50

Q46706250-05A9D84C-4CA5-48DD-B920-892F68C8592F

Q46706250-313D84A9-2399-428C-9FBD-AFDAB92E355B

P577

Q46706250-E507F811-C9EE-4582-A89D-0324023B2CBA

P5875

Q46706250-30B7B9A1-C16A-4E74-906A-B0B017E48460

P698

Q46706250-4303A06A-6345-4EAD-A301-5F2037B4CD01

P356

1078-0432.CCR-04-2458

P1433

Clinical Cancer Research

P1476

EphB2 expression across 138 hu ...... n in gastrointestinal cancers.

@en

P2093

Alessandro Lugli

http://www.w3.org/2001/XMLSchema#string

David Azorsa

http://www.w3.org/2001/XMLSchema#string

Guido Sauter

http://www.w3.org/2001/XMLSchema#string

Hanspeter Spichtin

http://www.w3.org/2001/XMLSchema#string

Jeff Kiefer

http://www.w3.org/2001/XMLSchema#string

Luigi Terracciano

http://www.w3.org/2001/XMLSchema#string

Martina Mirlacher

http://www.w3.org/2001/XMLSchema#string

Pia Huusko

http://www.w3.org/2001/XMLSchema#string

Robert Maurer

http://www.w3.org/2001/XMLSchema#string

Spyro Mousses

http://www.w3.org/2001/XMLSchema#string

P304

6450-6458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-04-2458

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7597570

http://www.w3.org/2001/XMLSchema#string

P698

16166419

http://www.w3.org/2001/XMLSchema#string